Premium
Prenatal screening for cystic fibrosis: attitudes and responses of participants
Author(s) -
Mennie Moira,
Compton Mary,
Gilfillan Annette,
Axton R. A.,
Liston W. A.,
Pullen I.,
Whyte Dorothy,
Brock D. J. H.
Publication year - 1993
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/j.1399-0004.1993.tb03856.x
Subject(s) - cystic fibrosis , carrier testing , heterozygote advantage , prenatal diagnosis , newborn screening , medicine , genetic counseling , genetic testing , pregnancy , gynecology , pediatrics , fetus , genetics , biology , genotype , gene
Mennie M, Compton M, Gilfillan A, Axton RA, Liston WA, Pullen I, Whyte D, Brock DJH. Prenatal screening for cystic fibrosis: attitudes and responses of participants. Clin Genet 1993: 44: 102–106. © Munksgaard, 1993 A screening programme to detect cystic fibrosis heterozygotes has been running in the antenatal climes of a major Edinburgh maternity hospital for more than 2 years. A questionnaire was used to assess participants' knowledge of the genetics of the disorder and their attitudes to being screened. The respondents were 64 female heterozygotes and 63 of their non‐heterozygous male partners, 101 female controls and 100 male controls. Although the two groups of controls received far less direct information than the carriers and their partners, all four groups were well informed about the genetics of cystic fibrosis and the significance of being a gene carrier. A majority of each group felt that adequate information had been given in the information leaflet, that they understood the purpose of screening and that they were glad to have participated. There was a consensus that CF carrier testing should be routinely offered to pregnant women, and also that it should be available in family planning clinics and GP health centres, but not in schools.